Kim Westerdijk
5PUBLICATIONS
2CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Dec 17, 2023
Real-world data on the management of pazopanib-induced liver toxicity in routine care of renal cell cancer and soft tissue sarcoma patients.K Westerdijk, S D Krens, N Steeghs
|Oct 30, 2023
Therapeutic drug monitoring to personalize dosing of imatinib, sunitinib, and pazopanib: A mixed methods study on barriers and facilitators.Kim Westerdijk, Neeltje Steeghs, Casper S J Tacke
|May 03, 2020
The relationship between sunitinib exposure and both efficacy and toxicity in real-world patients with renal cell carcinoma and gastrointestinal stromal tumour.Kim Westerdijk, Stefanie D Krens, Winette T A van der Graaf
|Nov 30, 2019
Imatinib, sunitinib and pazopanib: From flat-fixed dosing towards a pharmacokinetically guided personalized dose.Kim Westerdijk, Ingrid M E Desar, Neeltje Steeghs
|Feb 28, 2019
The value of the neutrophil-lymphocyte count ratio in the diagnosis of sepsis in patients admitted to the Intensive Care Unit: A retrospective cohort study.Kim Westerdijk, Koen S Simons, Marissa Zegers
Pageof 1
